These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19020508)

  • 1. Obesity, weight loss, and cardiovascular health: is oxidative capacity a missing link?
    Phillips SA
    Am J Hypertens; 2008 Dec; 21(12):1277. PubMed ID: 19020508
    [No Abstract]   [Full Text] [Related]  

  • 2. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
    Clifton PM; Bastiaans K; Keogh JB
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Obesity paradox].
    Aursulesei V; Cozma A; Datcu MD
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1006-15. PubMed ID: 20191867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of lactate with blood pressure before and after rapid weight loss.
    Crawford SO; Ambrose MS; Hoogeveen RC; Brancati FL; Ballantyne CM; Young JH
    Am J Hypertens; 2008 Dec; 21(12):1337-42. PubMed ID: 18802433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, weight loss and conditional cardiovascular risk factors.
    Tzotzas T; Evangelou P; Kiortsis DN
    Obes Rev; 2011 May; 12(5):e282-9. PubMed ID: 21054756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and cardiovascular risk: the new public health problem of worldwide proportions.
    Scaglione R; Argano C; Di Chiara T; Licata G
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):203-12. PubMed ID: 15151469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate metabolism, insulin resistance, and metabolic cardiovascular syndrome.
    Vaaler S
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S11-4. PubMed ID: 1283763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease.
    Miller WM; Nori Janosz KE; Yanez J; McCullough PA
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):743-59. PubMed ID: 16076283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obesity and cardiovascular morbidity].
    Berg A; Bönner G
    Dtsch Med Wochenschr; 2005 Apr; 130(14):893-7. PubMed ID: 15800824
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of obesity-related hypertension].
    Skoczylas A
    Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence.
    Sinaiko AR; Steinberger J; Moran A; Prineas RJ; Vessby B; Basu S; Tracy R; Jacobs DR
    Circulation; 2005 Apr; 111(15):1985-91. PubMed ID: 15837953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the benefits of moderate weight loss?
    de Leiva A
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():10-3. PubMed ID: 9792475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid and oxidative stress: relative impact on cardiovascular risk?
    Strazzullo P; Puig JG
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-fat or low-carbohydrate diet for cardiovascular health.
    Best D; Grainger P
    Can J Cardiovasc Nurs; 2007; 17(3):19-26. PubMed ID: 17941565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of glycaemic index in the prevention of cardiovascular diseases.
    Ukleja A; Kunachowicz H; Pachocka L
    Rocz Panstw Zakl Hig; 2007; 58(1):145-51. PubMed ID: 17711103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA; Kuipers F; Stolk RP
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.